These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 28488090)

  • 1. Pathogenesis of systemic sclerosis-current concept and emerging treatments.
    Furue M; Mitoma C; Mitoma H; Tsuji G; Chiba T; Nakahara T; Uchi H; Kadono T
    Immunol Res; 2017 Aug; 65(4):790-797. PubMed ID: 28488090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
    Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
    Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of B Cells in the Pathogenesis of Systemic Sclerosis.
    Sakkas LI; Bogdanos DP
    Isr Med Assoc J; 2016 Sep; 18(9):516-519. PubMed ID: 28471595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonistic antibodies in systemic sclerosis.
    Moroncini G; Svegliati Baroni S; Gabrielli A
    Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
    Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
    Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional autoantibodies in systemic sclerosis pathogenesis.
    Kill A; Riemekasten G
    Curr Rheumatol Rep; 2015 May; 17(5):34. PubMed ID: 25876754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of B cells in the pathogenesis of systemic sclerosis.
    Sanges S; Guerrier T; Launay D; Lefèvre G; Labalette M; Forestier A; Sobanski V; Corli J; Hauspie C; Jendoubi M; Yakoub-Agha I; Hatron PY; Hachulla E; Dubucquoi S
    Rev Med Interne; 2017 Feb; 38(2):113-124. PubMed ID: 27020403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.
    Ntelis K; Solomou EE; Sakkas L; Liossis SN; Daoussis D
    Semin Arthritis Rheum; 2017 Dec; 47(3):409-417. PubMed ID: 28602360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cells in systemic sclerosis: emerging evidence from genetics to phenotypes.
    Wu M; Mohan C
    Curr Opin Rheumatol; 2015 Nov; 27(6):537-41. PubMed ID: 26285102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis.
    Riemekasten G; Philippe A; Näther M; Slowinski T; Müller DN; Heidecke H; Matucci-Cerinic M; Czirják L; Lukitsch I; Becker M; Kill A; van Laar JM; Catar R; Luft FC; Burmester GR; Hegner B; Dragun D
    Ann Rheum Dis; 2011 Mar; 70(3):530-6. PubMed ID: 21081526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Yoshizaki A
    J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting interferons as a strategy for systemic sclerosis treatment.
    Ciechomska M; Skalska U
    Immunol Lett; 2018 Mar; 195():45-54. PubMed ID: 29106987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.